Zoetis Inc. (ZTS)

NYQ – Real Time Price. Currency in USD

76.94

+0.27 (0.35%)

At close: May 12, 2026, 4:00 PM EDT

77.43

+0.48 (0.62%)

Pre-market: May 13, 2026, 4:39 AM EDT

10.05.2026

Zoetis Q1 Review: Is A Darkened Outlook Cyclical Or Structural? (Rating Downgrade)

Zoetis faces intensified US companion animal sales declines, notably from generic competition impacting key legacy drugs, Convenia and Cerenia. Despite a 30% stock drop and valuation at 12x 2026 EPS, structural headwinds from patent expirations outweigh cyclical pressures in the near term. Q1 results showed a dramatic 11% YoY decline in US companion animal sales, partially offset by international and livestock segment growth.

09.05.2026

Zoetis: Significant Patience Required

Zoetis (ZTS) faces significant competitive and pricing headwinds, with shares down 37% YTD and trading at a five-year low. ZTS reported rare misses on both top and bottom lines, driven by US companion animal weakness, generics pressure, and reduced clinic visits. Guidance for 2026 remains intact, with revenue of $9.68–$9.96B and adjusted EPS of $6.85–$7.00, supported by upcoming product catalysts.

09.05.2026

10 Dividend Growth Stocks: May 2025

Dividend growth stocks have a streak of at least 5 consecutive years of dividend increases. I rank a selection of dividend growth stocks and present the top 10 stocks for consideration. To rank stocks, I do a quality assessment and sort candidates by quality scores. My new quality scoring system rates dividend stocks on a 10-point scale across 9 weighted factors. Each factor blends qualitative signals and quantitative metrics.

08.05.2026

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Zoetis Inc.

MILWAUKEE, May 7, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Zoetis (NYSE: ZTS). The investigation results from inaccurate statements Zoetis may have made regarding its financial statements, business operations and prospects.

07.05.2026

Zoetis Inc. (ZTS) Q1 2026 Earnings Call Transcript

07.05.2026

Why Zoetis Shares Plummeted Today

Zoetis delivered sales and adjusted earnings per share growth of 3% and 9%, which was below analysts' expectations. Worse yet, its guidance for 2026 was also weak, as pet owners may be hitting a ceiling on how much they can afford to pay to help their furry friends.

07.05.2026

Zoetis Q1 Earnings Lag Estimates, 2026 View Cut, Stock Down

ZTS misses on Q1 earnings and cuts its 2026 revenue outlook as weaker U.S. companion animal sales pressured results, sending shares down in pre-market trading.

Videos

07.01.2026

Neutral

Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera

23.12.2025

Positive

Trade Tracker: Stephanie Link buys mores Zoetis

05.08.2025

Neutral

Zoetis CEO: It's unclear if animal health will be a part of pharmaceutical tariffs

Press releases

08.05.2026

Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Zoetis Inc.

07.05.2026

Zoetis Announces First Quarter 2026 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the first quarter of 2026. The company reported revenue of $2.3 billion for the first quarter of 2026, an increase of 3% compared with the first quarter of 2025 and flat on an organic operational1 basis. Net income for the first quarter of 2026 was $601 million, or $1.42 per diluted share, reflecting flat performance and growth of 6%, respectively, on a.

12.03.2026

Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, will participate in a fireside chat at the KeyBanc Capital Markets Healthcare Forum on Tuesday, March 17, 2026 at 10:30 a.m. ET. Interested parties can access the live audio webcast of the presentation by visiting https://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoetis is the worl.

02.03.2026

Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to acquire animal genomics business from Neogen, strengthening the company's leadership in Precision Animal Health.

Zoetis Inc. (ZTS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Zoetis Inc. (ZTS)